Kellerhals Carrard with CGC on pre-seed financing round
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million.
The context
Several impact and health-tech investors led the operation, including Heal Capital, Becker Ventures, Springboard Health Angels, Superangels, and better ventures.
After successful closing of its pre-seed round, CGC Genomics Consults aims to finilise its clinical validation, enter the market and eventually introduce its GenAI platform Qnomx to the international public.
The Kellerhals Carrard team
Partner Umberto Milano (VC/M&A, pictured) led the Kellerhals Carrard startup & VC desk team on the matter, working alongside partner Karim Maizar (VC/M&A), associate Simon Gluch (VC/M&A) and paralegal Lisa Schmid.
